Développement de méthodes analytiques pour la détection et la quantification de traces de produits pharmaceutiques dans les eaux
du fleuve Saint Laurent
This project aims to document the need to increase our knowledge of organic contaminants such as pharmaceuticals in the environment and to assess their environmental fate. We studied the presence of pharmaceutical compounds in different water samples. We studied their presence in wastewater samples from the treatment plant of the City of Montreal, effluents, surface and tap water. To do this we developed two analytical methods based on solid phase extraction (SPE) coupled to liquid chromatography -tandem mass spectrometry (LC-MS/MS). . The performance of three atmospheric pressure ionization (API) techniques was also studied for their subsequent use in the developed method. It was demonstrated that electrospray ionization (ESI) is a more effective ionization method for the analysis of pharmaceutical contaminants in samples as complex as wastewaters. A first analytical LC-MS/MS method, was developed and validated for the investigation of samples from the wastewater treatment plant and surface waters near the plant of Montreal. Five prescription drugs were studied: bezafibrate (lipid regulator), cyclophosphamide, and methotrexate (two anticancer agents), orlistat (an anti-obesity agent) and enalapril used in the treatment of hypertension. Most of these drugs are excreted by the human body in high percentages and released into domestic wastewaters, making their way to the municipal wastewater treatment plants. It was demonstrated that there is a low rate of elimination at the wastewater treatment plant for bezafibrate and enalapril. These two compounds were also detected in surface waters on a site close to the discharge of the treatment plant effluents. For this first analytical method we observed the necessity of improvement of the detection limits of the method. A second method was then developed to improve the detection limits and to study a total of 14 organic contaminants, including three antiinfective agents (clarithromycin, sulfamethoxazole and trimethoprim), an anticonvulsant (carbamazepine) and its degradation product 10,11-dihydrocarbamazepine, the iii antihypertensive agent (enalapril), two antineoplastic (methotrexate and cyclophosphamide), herbicides (atrazine, cyanazine, and simazine) and two transformation products of atrazine (desethylatrazine and déisopropylatrazine) and an antiseptic agent (triclocarban). These products were quantified in surface water and tap water. The improvement of the detection limits of this method was possible due to the loading of a greater sample volume than that used in the first method (10 mL vs 1 mL). Other confirmation techniques, such as the data-dependent reverse energy ramp scan on a triple quadrupole and accurate mass measurements on a time-of-flight mass spectrometer were explored. Using time-of-flight mass spectrometer determinations allowed the confirmation of six of the 14 analytes. Finally, due to their toxic properties, the oxidation kinetics of cyclophosphamide and methotrexate with molecular ozone and OH radicals was studied in bench scale. The degradation constants with molecular ozone were calculated and the water quality after treatment was assessed. The overall process performance was improved for cyclophosphamide in natural waters, due to the combination of direct and indirect reactions. The study showed that ozone is very effective for the oxidation of methotrexate, but cyclophosphamide is too slowly oxidized for an effective drinking water treatment under usual conditions.
LC-MS/MS LC-MS/MS pharmaceutical compounds surface waters wastewater drinking water solid-phase extraction